glp 1 medications mechanism of action Frontiers GLP-1-based therapies for type 2

Gastroenterology 125 (1), 136147 (2003)

Lightheadedness that interferes with daily activities, increases fall risk, or causes significant anxiety warrants discussion with a healthcare provider

It can help in the repair of damaged skin, offering a protective barrier against pollutants

Common adverse effects are predominantly gastrointestinal and typically emerge during dose escalation: Nausea (affecting 2050% of users initially) Vomiting and diarrhoea Constipation Abdominal pain and bloating Reduced appetite (therapeutic effect but may be excessive) Fatigue and headache Injection site reactions (redness, swelling or itching) These effects usually diminish over several weeks as the body adjusts

Although the hereditary factors cannot be modified, but a lot improvement can be brought about as far as the lifestyle and environmental factors are concerned